Alonso Krangle LLP Alerts Fosamax Users to New Study Linking Long-Term Use of … - YAHOO!

Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims of harmful drugs, are alerting Fosamax users to a new study confirming the association between atypical femur fractures and long-term use of ...

Bernstein Liebhard LLP Reports On New Study Finding Risk of Fosamax Thigh Fractures - PRWeb

Bernstein Liebhard LLP reports on a new study that found an increased risk of atypical femur fractures in people who take Fosamax. Bernstein Liebhard LLP, a nationwide law firm representing clients who experienced Fosamax thigh fractures and other side ...

Merck Barred From Contacting Plaintiff Doctors in Fosamax Fracture Suits - AboutLawsuits.com

Citing physician-patient privilege, a federal judge has barred Merck from directly contacting the doctors of patients who have filed a lawsuit after suffering bone fractures allegedly caused by the osteoporosis drug Fosamax.  In a court order (PDF) issued ...

FDA Report Cautioning Long-Term Use of Fosamax and Other Bisphosphonate Drugs Acknowledged by Rottenstein Law Group - 24-7PressRelease.com

The Rottenstein Law Group has learned of a new FDA report cautioning against the long-term use of Fosamax and other bisphosphonate drugs for the treatment of osteoporosis. NEW YORK, NY, May 16, 2012 /24-7PressRelease/-- The Rottenstein Law Group, which ...

Bone drugs linked to rare thigh fractures - FOX News

Widely used osteoporosis drugs such as Fosamax and Actonel significantly raise the risk for a rare but serious thigh fracture and that risk rises the longer patients take the medicines, a new study found. Some women 50 and older have been taking ...

New Cautions About Long-Term Use of Bone Drugs - New York Times Blogs

A study of Fosamax, which is sold generically as alendronate, continued for 10 years, and a study of Reclast, an injectable form of the drug zoledronic acid, continued for six years. According to the F.D.A. analysis, both studies showed ...

FDA Bisphosphonate Study Finds Few Benefits from Long-Term Use - Newsinferno.com

A new U.S. Food & Drug Administration (FDA) analysis is raising serious concerns about the long-term use of bisphosphonates like Fosamax to treat weak bones. While the bisphosphonate analysis found little if any benefit from taking the drugs for ...

Long-Term Bisphosphonates May Be OK for Select Patients - Medscape News

The FDA focused their review on 3 long-term extension trials that evaluated bisphosphonate treatment for from 6 to 10 years: the Fosamax Fracture Intervention Trial Long-Term Extension (FLEX), the Reclast Health Outcomes and Reduced Incidence with ...

FDA’s Stance on Bisphosphonate Drugs - WebMD

The FDA is weighing in on how long is long enough to take bisphosphonates – a widely used class of osteoporosis drugs that includes Actonel, Atelvia, Boniva, and Fosamax. The short answer: It depends, but 5 years may be the key time frame. After that ...

Why Were Risky, Ineffectual Bone Drugs Approved, Some Are Asking - Food Consumer

Like Vioxx, Merck's expensive "super aspirin" that caused thousands of cardiovascular events before being recalled, Merck's Fosamax, the first bisphosphonate bone drug, flew out of the FDA with only a six-month review. And like Vioxx, the true dangers of ...